Register of
Medicinal Products

Product class: Authorized package
Medicinal product class: Veterinary medicine
Package code: 1693368
Name of medicinal product: Betafuse
Active substances:
Betamethasone+Fusidic acid
Estonian, English, Latin
ATC code: QD07CC80
Dosage form: gel
Route of administration: cutaneous use
Strengh: 1mg+5mg 1g
Amount in package: 15g 1TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication: For the treatment of acute surface pyoderma in the dog, such as acute moist dermatitis (‘hot spots’) and intertrigo (skin fold dermatitis), caused by Gram-positive bacteria sensitive to fusidic acid.
Safety features: No
Summary of product characteristics (SPC):  (last updated September 2, 2021)
Package information leaflet (PIL): EST  (last updated September 2, 2021)
Labelling:  (last updated September 2, 2021)
Withdrawal time: Ei rakendata.
Species: koer
Last imported to Estonia: February 9, 2023
Marketing authorization holder: Norbrook Laboratories (Ireland) Limited 
Marketing authorization number: 1992 
Marketing authorization issued on: September 30, 2016 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Decentralised 
Entry/Changing date: March 4, 2024
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere